CH Biotech R&D Co., Ltd. (TPE:6534)

Market Cap	9.52B
Revenue (ttm)	1.77B
Net Income (ttm)	439.33M
Shares Out	102.80M
EPS (ttm)	4.25
PE Ratio	21.80
Forward PE	n/a
Dividend	4.10 (4.40%)
Ex-Dividend Date	Aug 21, 2025

Volume	68,709
Average Volume	191,202
Open	92.70
Previous Close	92.60
Day's Range	92.60 - 96.00
52-Week Range	71.10 - 123.50
Beta	0.17
RSI	46.99
Earnings Date	Nov 5, 2025

About CH Biotech R&D

CH Biotech R&D Co., Ltd., a biotech company, engages in the research and development of biotech drugs for agrochemical products in Taiwan, the United States, and internationally. The company offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd. was incorporated in 2013 and is based in Nantou City, Taiwan.

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2013
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6534

Financial Performance

In 2024, CH Biotech R&D's revenue was 1.64 billion, an increase of 7.98% compared to the previous year's 1.51 billion. Earnings were 476.39 million, an increase of 2.83%.